Shop2011
NanoCellect Biomedical Inc., is incorporated.
2013
NanoCellect Biomedical Inc. first patent is issued.
2015
NanoCellect Biomedical Inc., begins a collaboration with UCSD to develop single cell genomic applications based on their WOLF Cell Sorter.
2016
NanoCellect Biomedical Inc. closes $1.75M Series A financing round and will begin production of their WOLF Cell Sorter.
Rick Segil and Jack Ball join the NanoCellect family to gear up for commercial launch of the WOLF Cell Sorter.
The National Institute on Drug Abuse at the NIH has awarded NanoCellect Biomedical Inc. with a new SBIR Grant aimed at developing an Imaging Flow Cytometer.
NanoCellect Biomedical Inc. officially launches the WOLF Cell Sorter at CYTO 2016.
The WOLF Cell Sorter is selected as one of the Finalists for Most Innovative New Product Awards by CONNECT.
2017
NanoCellect Biomedical, Inc. announces its upcoming launch of the N1 Single Cell Dispenser for the WOLF® Cell Sorter.
NanoCellect Biomedical Inc. gets $3M from NIH for single cell and image-based flow cytometry.
NanoCellect Biomedical Inc. announces the completion of a $10 million Series B financing round, including convertible notes.
2018
Chris Neary joins NanoCellect Biomedical Inc. as Chief Executive Officer.
NanoCellect Biomedical Inc. extends its footprint in San Diego expanding into additional facilities to accommodate business growth.
NanoCellect Biomedical Inc. presents at Illumina Venture’s annual investor summit.
NanoCellect Biomedical Inc. announces a new travel award program designed to stimulate novel application of the company’s cell sorting technology.
2019
NanoCellect Biomedical, Inc. announces that Paul DiGregorio, Ph.D. has joined the company as its new Vice President of Commercial to lead NanoCellect’s global commercial expansion efforts and oversee the company’s sales, marketing, customer support, and product teams.
NanoCellect Biomedical Inc. announces a collaboration with the Parnassus Flow Cytometry Core facility at the University of California, San Francisco (UCSF).
NanoCellect Biomedical Inc. announces an exclusive distribution agreement with Basel, Switzerland-based Bucher Biotec AG.
NanoCellect Biomedical Inc. announces the selection of Seoul-based DAON BioSciences as exclusive distributor in the South Korea market.
QIAGEN N.V. and NanoCellect Biomedical, Inc., announces a scientific collaboration to improve the cell sample prep upstream of QIAGEN’s QIAseq® UPX 3′ Transcriptome Kit through the utilization of NanoCellect’s WOLF Cell Sorter technology, which allows for individual cells to be gently sorted into RNAseq- ready 96-well plates.
NanoCellect Biomedical Inc. announces an exclusive agreement with Millennium Science to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Australia and New Zealand.
NanoCellect Biomedical, Inc. announces that is has been added to the 10x Genomics’ Compatible Product Partner Program.
NanoCellect Biomedical, Inc. announces that Jeremy Baker has joined the company as its new Vice President of Finance.
NanoCellect Biomedical Inc. announces it has received a $1.5 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National Institute on Drug Abuse to continue its development of imaging flow cytometry technology to sort cells based on high-content 3D image features.
NanoCellect Biomedical Inc. announces an exclusive agreement with Singapore-based Research Instruments Pte Ltd to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Singapore, Thailand, Malaysia, and Vietnam.
NanoCellect Biomedical Inc. announces an exclusive agreement with Denmark-based RAMCON to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Denmark, Finland, Iceland, Norway and Sweden.
2020
NanoCellect Biomedical Inc. announces a distribution and partnership agreement with China-based Novogene to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in China.
Akadeum Life Sciences, Inc. and NanoCellect Biomedical, Inc. jointly announce a new collaboration to improve rare-cell workflows.
NanoCellect Biomedical Inc. Partners with Filgen for Distribution of Cell Sorting Solutions in Japan.
NanoCellect Biomedical Inc. announces it has completed agreements with several key partners to distribute its WOLF® Cell Sorter throughout East Asia and Western Europe.
2021
NanoCellect Biomedical Inc. announces the virtual launch, scheduled for May 18, 2021, of the WOLF G2 Cell Sorter, the newest addition to NanoCellect’s family of products.
NanoCellect Biomedical Inc. announces it has completed agreements with two key partners to distribute its WOLF and WOLF G2 Cell Sorters throughout Eastern Europe, Middle East, Africa and Western Asia.
NanoCellect Biomedical Inc. accelerates growth plans with close of $35 Million in Series C & D Rounds led by Vertical Venture Partners and Warburg Pincus.
NanoCellect Biomedical Inc. signs an agreement appointing Alliance Global (AGBL Group) as the exclusive distributor in the Middle East, Africa, Levant, Turkey, Pakistan, Bangladesh and Sri Lanka.
2022
Fluent BioSciences and NanoCellect Biomedical Inc. announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations.
NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies